Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Alkem Laboratories Ltd. ( (IN:ALKEM) ) has provided an announcement.
Alkem Laboratories Ltd. has announced its participation in the Equirus Annual India Conference, scheduled for August 20, 2025, in Mumbai. The meeting will be an in-person, one-on-one session with analysts and institutional investors, indicating the company’s proactive engagement with stakeholders to discuss its strategic direction and performance.
More about Alkem Laboratories Ltd.
Alkem Laboratories Ltd. operates in the pharmaceutical industry, focusing on the development, manufacture, and sale of pharmaceutical products. The company is known for its wide range of generic and branded drugs, catering to various therapeutic segments.
Average Trading Volume: 44,299
Technical Sentiment Signal: Hold
Current Market Cap: 569.6B INR
Find detailed analytics on ALKEM stock on TipRanks’ Stock Analysis page.